1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Site back up

Discussion in 'Ortho Biotech' started by Anonymous, May 30, 2012 at 5:52 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Thank you for putting the OBI site back up.
     

  2. Anonymous

    Anonymous Guest

    Hey big rumor mill out there that Ortho Diagnostics is being sold and Rhogam will be discontinued?
     
  3. Anonymous

    Anonymous Guest

    I have been hearing the same.